[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Pulse On Market [@PulseOnMarket](/creator/twitter/PulseOnMarket) on x 4559 followers Created: 2025-07-14 23:07:51 UTC 🚨 What’s going on with $TEM After a monster run earlier this year, Tempus AI is down ~30% from its Feb highs but the story’s far from over. Here’s a quick breakdown: 👇 Tempus is expanding rapidly: 💡New liquid biopsy & minimal residual disease assays 💡$650M convertible note raise (0.75% interest) 💡Expanded partnerships w/ health systems & $PSNL 💡Rolled out Tempus Next (clinical AI) + Tempus One (EHR-integrated LLM) But also… ⏳Stock has cooled off… Now trading around $XX (from ~$91 peak) ⏳Multiple shareholder investigations opened in June ⏳Broader pullback in AI-healthtech names like $PLTR & $NVTA Next major catalyst? Q2 earnings Aug X Still one of the most compelling AI/biotech crossover plays out there, but market sentiment has clearly reset. #AI #HealthTech #Biotech #Stocks  XXXXX engagements  **Related Topics** [$psnl](/topic/$psnl) [$650m](/topic/$650m) [liquid](/topic/liquid) [coins ai](/topic/coins-ai) [$tem](/topic/$tem) [Post Link](https://x.com/PulseOnMarket/status/1944896653879820458)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Pulse On Market @PulseOnMarket on x 4559 followers
Created: 2025-07-14 23:07:51 UTC
🚨 What’s going on with $TEM
After a monster run earlier this year, Tempus AI is down ~30% from its Feb highs but the story’s far from over.
Here’s a quick breakdown: 👇
Tempus is expanding rapidly:
đź’ˇNew liquid biopsy & minimal residual disease assays đź’ˇ$650M convertible note raise (0.75% interest) đź’ˇExpanded partnerships w/ health systems & $PSNL đź’ˇRolled out Tempus Next (clinical AI) + Tempus One (EHR-integrated LLM)
But also…
⏳Stock has cooled off… Now trading around $XX (from ~$91 peak) ⏳Multiple shareholder investigations opened in June ⏳Broader pullback in AI-healthtech names like $PLTR & $NVTA
Next major catalyst? Q2 earnings Aug X
Still one of the most compelling AI/biotech crossover plays out there, but market sentiment has clearly reset.
#AI #HealthTech #Biotech #Stocks
XXXXX engagements
/post/tweet::1944896653879820458